Revenue - Novogene Co Ltd (SSE:688315) - Alpha Spread

Novogene Co Ltd
SSE:688315

Watchlist Manager
Novogene Co Ltd Logo
Novogene Co Ltd
SSE:688315
Watchlist
Price: 9.45 CNY -3.67% Market Closed
Market Cap: 3.9B CNY
Have any thoughts about
Novogene Co Ltd?
Write Note

Novogene Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Novogene Co Ltd
Revenue Peer Comparison

Comparables:
603259
300759
2269
300347
1548

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Novogene Co Ltd
SSE:688315
Revenue
ÂĄ2B
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Revenue
ÂĄ38.7B
CAGR 3-Years
25%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Revenue
ÂĄ11.5B
CAGR 3-Years
23%
CAGR 5-Years
29%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Revenue
ÂĄ17.1B
CAGR 3-Years
28%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Revenue
ÂĄ7B
CAGR 3-Years
23%
CAGR 5-Years
22%
CAGR 10-Years
33%
Genscript Biotech Corp
HKEX:1548
Revenue
$1B
CAGR 3-Years
31%
CAGR 5-Years
33%
CAGR 10-Years
N/A

See Also

What is Novogene Co Ltd's Revenue?
Revenue
2B CNY

Based on the financial report for Dec 31, 2023, Novogene Co Ltd's Revenue amounts to 2B CNY.

What is Novogene Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
14%

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Novogene Co Ltd have been 10% over the past three years , 14% over the past five years .

Back to Top